Navigation Links
A Breakthrough Discovery on Treating Resistant Biofilm Infections Was Presented January 12 at Medtech Showcase in San Francisco
Date:1/13/2016

COLUMBUS, Ohio, Jan. 13, 2016 /PRNewswire/ -- Details regarding a breakthrough medical discovery with tremendous potential for treatment of patients with serious bacterial infections were presented on January 12 to pharmaceutical leaders and public and private investors attending the Medtech Showcase in San Francisco. 

Logo - http://photos.prnewswire.com/prnh/20160112/321484LOGO

Steven Goodman, Ph.D., a member of the Scientific Board for ProclaRx and Associate Professor of Pediatrics at the Ohio State College of Medicine, and Principal Investigator at the Research Institute of Nationwide Children's Hospital, spoke about a new technology developed by ProclaRx, an Ohio-based biotechnology company, to break down and destroy biofilms.  Biofilms are a physical barrier which protect bacteria and prevent antibiotics and the body's immune system from eradicating chronic infections.

Infections with biofilms are associated with indications as those found in advanced wound care, chronic draining ear infections, and CVID sinusitis. They are highly resistant to antibiotics and have a significant ability to evade normal defenses against bacteria. Recurrent infections and antibiotic resistance is a major clinical and public health problem, with bacterial biofilms implicated in more than 80% of infections.

"Dr. Goodman's presentation clearly demonstrated the power of the anti-biofilm technology. This technology is unusual in that it can support both therapeutic as well as medical device products," stated Joseph D. Kittle, Jr., Ph.D., and CEO for ProclaRx.

Founded in 2014, ProclaRx has exclusive worldwide rights to develop and commercialize anti-infective technology from Nationwide Children's Hospital and the University of Southern California. With $5.5 million invested to-date, they are seeking additional financing and strategic partners. Medtech Showcase is part of the Biotech Showcase, one of the healthcare industry's largest annual healthcare investor conferences.   

About ProclaRx  
ProclaRx is a biotechnology company developing innovative therapeutics for patients suffering from serious bacterial infections. ProclaRx has a breakthrough discovery that inhibits and prevents bacterial biofilms. Lead indications include advanced wound care, secretory otitis media and CVID sinusitis. Visit www.proclarx.com or call 949-302-2165 or e-mail info@proclarx.com.

Contact:  Dr. Joseph D. Kittle, Jr. 
CEO, ProclaRx 
949-302-2165  

 


'/>"/>
SOURCE ProclaRx
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible
2. Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
3. Pressure BioSciences Announces Core Technology Breakthrough
4. Zydus Pioneers a Breakthrough With LIPAGLYN, Indias First NCE to Reach the Market
5. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
6. Orthocare Innovations Once Again Recognized for Top Honors for its Breakthrough Prosthetic Foot Ankle System
7. AlignMeds Breakthrough Garment Technology Gets a YES from the FDA!
8. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
9. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
10. Facebook and Twitter Drive Frenzy for Breakthrough "Anti-Aging Pill"
11. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):